Total Payments
$22,547
2024 Payments
$523.26
Companies
23
Transactions
208
Medicare Patients
494
Medicare Billing
$174,290
Payment Breakdown by Category
Other$12,145 (53.9%)
Travel$3,580 (15.9%)
Food & Beverage$3,520 (15.6%)
Consulting$3,000 (13.3%)
Education$302.30 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,145 | 9 | 53.9% |
| Travel and Lodging | $3,580 | 7 | 15.9% |
| Food and Beverage | $3,520 | 186 | 15.6% |
| Consulting Fee | $3,000 | 1 | 13.3% |
| Education | $302.30 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $11,929 | 30 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $7,823 | 31 | $0 (2023) |
| Alkermes, Inc. | $452.37 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $433.46 | 25 | $0 (2024) |
| ABBVIE INC. | $358.47 | 25 | $0 (2024) |
| Indivior Inc. | $278.97 | 20 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $277.67 | 6 | $0 (2023) |
| Allergan, Inc. | $246.28 | 10 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $111.01 | 6 | $0 (2024) |
| LivaNova USA, Inc. | $95.16 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.26 | 26 | LivaNova USA, Inc. ($95.16) |
| 2023 | $1,028 | 51 | Teva Pharmaceuticals USA, Inc. ($277.67) |
| 2022 | $458.21 | 31 | ABBVIE INC. ($161.79) |
| 2021 | $352.18 | 21 | Alkermes, Inc. ($99.96) |
| 2020 | $216.46 | 14 | Allergan, Inc. ($88.44) |
| 2019 | $249.80 | 11 | Allergan Inc. ($157.84) |
| 2018 | $8,199 | 31 | Neurocrine Biosciences, Inc. ($7,788) |
| 2017 | $11,520 | 23 | Otsuka America Pharmaceutical, Inc. ($11,483) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: CNS | ||||||
| 11/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neuroscience | ||||||
| 09/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $95.16 | General |
| Category: Neurology | ||||||
| 08/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CNS | ||||||
| 08/19/2024 | Noven Therapeutics, LLC | Secuado (Drug), Xelstrym | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CNS Psychiatry | ||||||
| 08/06/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: ADHD | ||||||
| 07/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Neuroscience | ||||||
| 07/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: OUD | ||||||
| 06/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Neuroscience | ||||||
| 06/04/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ADHD | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: CNS | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PSYCHIATRY | ||||||
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Neuroscience | ||||||
| 02/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ADHD | ||||||
| 02/14/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 108 | 600 | $80,345 | $39,757 |
| 2022 | 3 | 100 | 581 | $76,805 | $34,653 |
| 2021 | 3 | 109 | 685 | $91,225 | $41,744 |
| 2020 | 3 | 177 | 933 | $126,100 | $58,136 |
Total Patients
494
Total Services
2,799
Medicare Billing
$174,290
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 502 | $62,115 | $29,363 | 47.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 36 | 50 | $11,130 | $6,365 | 57.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 35 | 48 | $7,100 | $4,029 | 56.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 502 | $62,175 | $26,450 | 42.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 35 | 40 | $8,880 | $5,182 | 58.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 31 | 39 | $5,750 | $3,021 | 52.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 596 | $74,500 | $32,217 | 43.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 36 | 45 | $10,125 | $5,997 | 59.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 36 | 44 | $6,600 | $3,530 | 53.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 59 | 782 | $97,750 | $43,607 | 44.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 59 | 76 | $17,100 | $8,365 | 48.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 59 | 75 | $11,250 | $6,164 | 54.8% |
About Dr. Christopher White, M.D
Dr. Christopher White, M.D is a General Practice healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316987639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher White, M.D has received a total of $22,547 in payments from pharmaceutical and medical device companies, with $523.26 received in 2024. These payments were reported across 208 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,145).
As a Medicare-enrolled provider, White has provided services to 494 Medicare beneficiaries, totaling 2,799 services with total Medicare billing of $174,290. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Memphis, TN
- Active Since 06/07/2006
- Last Updated 04/30/2013
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316987639
Products in Payments
- REXULTI (Drug) $11,940
- INGREZZA (Drug) $7,823
- VRAYLAR (Drug) $604.75
- ARISTADA (Drug) $354.87
- INVEGA SUSTENNA (Drug) $273.27
- PERSERIS (Drug) $191.90
- SPRAVATO (Drug) $129.15
- XIFAXAN (Drug) $111.01
- Vivitrol 380 mg (Drug) $97.50
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $95.16
- SUBLOCADE (Drug) $87.07
- CAPLYTA (Drug) $76.90
- Dyanavel XR (Drug) $70.38
- TRINTELLIX (Drug) $63.69
- QUVIVIQ (Drug) $61.13
- Adzenys XR-ODT (Drug) $48.86
- ADHANSIA XR (Drug) $41.05
- APLENZIN (Drug) $40.38
- QELBREE (Drug) $31.06
- INVEGA TRINZA (Drug) $31.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Memphis
Dr. Elizabeth Mitchell, D.d.s, D.D.S
General Practice — Payments: $8,586
General Practice $8,586
Dr. Jodi Rump, Dds, DDS
General Practice — Payments: $7,676
General Practice $7,676
Howard Glenn, Dmd, DMD
General Practice — Payments: $6,022
General Practice $6,022
Dr. Jerry Lovelace, M.d, M.D
General Practice — Payments: $5,630
General Practice $5,630
Mr. Clayton Myers, Dds, DDS
General Practice — Payments: $5,125
General Practice $5,125
Jeffrey Ryu, Dmd, DMD
General Practice — Payments: $3,930
General Practice $3,930